ADIENT ($ADNT) posted quarterly earnings results on Wednesday, May 7th. The company reported earnings of $0.69 per share, beating estimates of $0.34 by $0.35. The company also reported revenue of $3,611,000,000, beating estimates of $3,512,786,925 by $98,213,075.
You can see Quiver Quantitative's $ADNT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ADIENT Insider Trading Activity
ADIENT insiders have traded $ADNT stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ADNT stock by insiders over the last 6 months:
- JAMES CONKLIN (EVP, Americas) sold 11,500 shares for an estimated $232,875
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ADIENT Hedge Fund Activity
We have seen 116 institutional investors add shares of ADIENT stock to their portfolio, and 127 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PACER ADVISORS, INC. removed 3,672,690 shares (-76.6%) from their portfolio in Q1 2025, for an estimated $47,230,793
- BARROW HANLEY MEWHINNEY & STRAUSS LLC removed 1,607,045 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $27,689,385
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC removed 1,519,992 shares (-29.2%) from their portfolio in Q4 2024, for an estimated $26,189,462
- UBS GROUP AG added 1,349,374 shares (+352.9%) to their portfolio in Q4 2024, for an estimated $23,249,714
- BLACKROCK, INC. removed 1,056,777 shares (-6.7%) from their portfolio in Q1 2025, for an estimated $13,590,152
- FMR LLC removed 1,047,504 shares (-11.1%) from their portfolio in Q4 2024, for an estimated $18,048,493
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 661,334 shares (+inf%) to their portfolio in Q4 2024, for an estimated $11,394,784
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ADIENT Analyst Ratings
Wall Street analysts have issued reports on $ADNT in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Negative" rating on 04/15/2025
To track analyst ratings and price targets for ADIENT, check out Quiver Quantitative's $ADNT forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
